ECOR vs. HSDT

In the year-to-date period, ECOR achieves a -71.31% return, which is significantly lower than HSDT's -58.23% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for electroCore, Inc. (ECOR) and Helius Medical Technologies, Inc. (HSDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ECOR Sharpe Ratio is -0.40, which is comparable to the HSDT Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of ECOR and HSDT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ECOR nor HSDT has paid dividends to shareholders.

The maximum ECOR drawdown since its inception was -98.95%, roughly equal to the maximum HSDT drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ECOR and HSDT. For additional features, visit the drawdowns tool.

electroCore, Inc. (ECOR) has a higher volatility of 37.43% compared to Helius Medical Technologies, Inc. (HSDT) at 29.72%. This indicates that ECOR's price experiences larger fluctuations and is considered to be riskier than HSDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between electroCore, Inc. and Helius Medical Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.